Modulation of type I interferon-associated viral sensing during acute simian immunodeficiency virus infection in African green monkeys

Journal of Virology

Volumn 89, Issue 1, 2015, Pages 751-762

  Jochems, Simon P ^a,b   Petitjean, Gaël ^a,d   Kunkel, Désirée ^a,e   Liovat, Anne Sophie ^a   Ploquin, Mickaël J ^a   Barré Sinoussi, Françoise ^a   Lebon, Pierre ^c   Jacquelin, Béatrice ^a   Müller Trutwin, Michaela C ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL SAINT VINCENT DE PAUL   (France)

^d INSTITUTE OF HUMAN GENETICS   (France)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CELL PROTEIN; CYTOKINE; GAMMA INTERFERON; HLA DR ANTIGEN; INTERFERON; PROTEIN BDCA 2; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CELLULAR IMMUNITY; CHLOROCEBUS AETHIOPS; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HERPES SIMPLEX; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO STUDY; LONGITUDINAL STUDY; MONONUCLEAR CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMAL; IMMUNOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS; VIROLOGY;

CERCOPITHECUS AETHIOPS; SIMIAN IMMUNODEFICIENCY VIRUS; SIMPLEXVIRUS;

ANIMALS; CERCOPITHECUS AETHIOPS; FLOW CYTOMETRY; INTERFERON TYPE I; LEUKOCYTES, MONONUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84919459055     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02430-14     Document Type: Article

References (54)

1. Kirchhoff F. 2010. Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 8:55-67. http://dx.doi.org/10.1016/j.chom.2010.06.004.
2. Fonteneau J-F, Larsson M, Beignon A-S, McKenna K, Dasilva I, Amara A, Liu Y-J, Lifson JD, Littman DR, Bhardwaj N. 2004. Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J Virol 78:5223-5232. http://dx.doi.org/10.1128/JVI.78.10.5223-5232.2004.
3. hi T regulatory cells. Eur J Immunol 35:2452-2458. http://dx.doi.org/10.1002/eji.200526069.
4. Karpov AV. 2001. Endogenous and exogenous interferons in HIVinfection. Eur J Med Res 6:507-524.
5. Asmuth DM, Murphy RL, Rosenkranz SL, Lertora JJ, Kottilil S, Cramer Y, Chan ES, Schooley RT, Rinaldo CR, Thielman N, Li XD, Wahl SM, Shore J, Janik J, Lempicki RA, Simpson Y, Pollard RB. 2010. Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial. J Infect Dis 201:1686-1696. http://dx.doi.org/10.1086/652420.
6. Jacquelin B, Petitjean G, Kunkel D, Liovat AS, Jochems SP, Rogers KA, Ploquin MJ, Madec Y, Barre-Sinoussi F, Dereuddre-Bosquet N, Lebon P, Le Grand R, Villinger F, Muller-Trutwin M. 2014. Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferon-alpha during primary SIVagm infection. PLoS Pathog 10:e1004241. http://dx.doi.org/10.1371/journal.ppat.1004241.
7. Vanderford TH, Slichter C, Rogers KA, Lawson BO, Obaede R, Else J, Villinger F, Bosinger SE, Silvestri G. 2012. Treatment of SIV-infected sooty mangabeys with a type-I IFN agonist results in decreased virus replication without inducing hyperimmune activation. Blood 119:5750-5757. http://dx.doi.org/10.1182/blood-2012-02-411496.
8. Azzoni L, Foulkes AS, Papasavvas E, Mexas AM, Lynn KM, Mounzer K, Tebas P, Jacobson JM, Frank I, Busch MP, Deeks SG, Carrington M, O'Doherty U, Kostman J, Montaner LJ. 2013. Pegylated interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration. J Infect Dis 207:213-222. http://dx.doi.org/10.1093/infdis/jis663.
9. Sandler NG, Bosinger SE, Estes JD, Zhu RT, Tharp GK, Boritz E, Levin D, Wijeyesinghe S, Makamdop KN, Del Prete GQ, Hill BJ, Timmer JK, Reiss E, Yarden G, Darko S, Contijoch E, Todd JP, Silvestri G, Nason M, Norgren RB, Jr, Keele BF, Rao S, Langer JA, Lifson JD, Schreiber G, Douek DC. 2014. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 511:601-605. http://dx.doi.org/10.1038/nature13554.
10. Hervas-Stubbs S, Perez-Gracia JL, Rouzaut A, Sanmamed MF, Le Bon A, Melero I. 2011. Direct effects of type I interferons on cells of the immune system. Clin Cancer Res 17:2619-2627. http://dx.doi.org/10.1158/1078-0432.CCR-10-1114.
11. Herbeuval JP, Boasso A, Grivel JC, Hardy AW, Anderson SA, Dolan MJ, Chougnet C, Lifson JD, Shearer GM. 2005. TNF-related apoptosisinducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells. Blood 105:2458-2464. http://dx.doi.org/10.1182/blood-2004-08-3058.
12. Sedaghat AR, German J, Teslovich TM, Cofrancesco J, Jr, Jie CC, Talbot CC, Jr, Siliciano RF. 2008. Chronic CD4+T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferonmediated disruption of T-cell dynamics. J Virol 82:1870-1883. http://dx.doi.org/10.1128/JVI.02228-07.
13. Liovat AS, Rey-Cuille MA, Lecuroux C, Jacquelin B, Girault I, Petitjean G, Zitoun Y, Venet A, Barre-Sinoussi F, Lebon P, Meyer L, Sinet M, Muller-Trutwin M. 2012. Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection. PLoS One 7:e46143. http://dx.doi.org/10.1371/journal.pone.0046143.
14. Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, Wen TF, Lindsay RJ, Orellana L, Mildvan D, Bazner S, Streeck H, Alter G, Lifson JD, Carrington M, Bosch RJ, Robbins GK, Altfeld M. 2009. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 15:955-959. http://dx.doi.org/10.1038/nm.2004.
15. Rotger M, Dalmau J, Rauch A, McLaren P, Bosinger SE, Martinez R, Sandler NG, Roque A, Liebner J, Battegay M, Bernasconi E, Descombes P, Erkizia I, Fellay J, Hirschel B, Miro JM, Palou E, Hoffmann M, Massanella M, Blanco J, Woods M, Gunthard HF, de Bakker P, Douek DC, Silvestri G, Martinez-Picado J, Telenti A. 2011. Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. J Clin Invest 121:2391-2400. http://dx.doi.org/10.1172/JCI45235.
16. Sodora DL, Allan JS, Apetrei C, Brenchley JM, Douek DC, Else JG, Estes JD, Hahn BH, Hirsch VM, Kaur A, Kirchhoff F, Muller-Trutwin M, Pandrea I, Schmitz JE, Silvestri G. 2009. Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med 15:861-865. http://dx.doi.org/10.1038/nm.2013.
17. Kornfeld C, Ploquin MJ, Pandrea I, Faye A, Onanga R, Apetrei C, Poaty-Mavoungou V, Rouquet P, Estaquier J, Mortara L, Desoutter JF, Butor C, Le Grand R, Roques P, Simon F, Barre-Sinoussi F, Diop OM, Muller-Trutwin MC. 2005. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest 115:1082-1091. http://dx.doi.org/10.1172/JCI200523006.
18. Liovat AS, Jacquelin B, Ploquin MJ, Barre-Sinoussi F, Muller-Trutwin MC. 2009. African non human primates infected by SIV: why don't they get sick? Lessons from studies on the early phase of nonpathogenic SIV infection. Curr HIV Res 7:39-50. http://dx.doi.org/10.2174/1570162097848546.
19. Bosinger SE, Li Q, Gordon SN, Klatt NR, Duan L, Xu L, Francella N, Sidahmed A, Smith AJ, Cramer EM, Zeng M, Masopust D, Carlis JV, Ran L, Vanderford TH, Paiardini M, Isett RB, Baldwin DA, Else JG, Staprans SI, Silvestri G, Haase AT, Kelvin DJ. 2009. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest 119:3556-3572. http://dx.doi.org/10.1172/JCI40115.
20. Jacquelin B, Mayau V, Targat B, Liovat AS, Kunkel D, Petitjean G, Dillies MA, Roques P, Butor C, Silvestri G, Giavedoni LD, Lebon P, Barre-Sinoussi F, Benecke A, Muller-Trutwin MC. 2009. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 119:3544-3555. http://dx.doi.org/10.1172/JCI40093.
21. Campillo-Gimenez L, Laforge M, Fay M, Brussel A, Cumont MC, Monceaux V, Diop O, Levy Y, Hurtrel B, Zaunders J, Corbeil J, Elbim C, Estaquier J. 2010. Nonpathogenesis of simian immunodeficiency virus infection is associated with reduced inflammation and recruitment of plasmacytoid dendritic cells to lymph nodes, not to lack of an interferon type I response, during the acute phase. J Virol 84:1838-1846. http://dx.doi.org/10.1128/JVI.01496-09.
22. Bosinger SE, Johnson ZP, Folkner KA, Patel N, Hashempour T, Jochems SP, Del Rio Estrada PM, Paiardini M, Lin R, Vanderford TH, Hiscott J, Silvestri G. 2013. Intact type I Interferon production and IRF7 function in sooty mangabeys. PLoS Pathog 9:e1003597. http://dx.doi.org/10.1371/journal.ppat.1003597.
23. Diop OM, Ploquin MJ, Mortara L, Faye A, Jacquelin B, Kunkel D, Lebon P, Butor C, Hosmalin A, Barre-Sinoussi F, Muller-Trutwin MC. 2008. Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome. J Virol 82:5145-5152. http://dx.doi.org/10.1128/JVI.02433-07.
24. Bruel T, Dupuy S, Demoulins T, Rogez-Kreuz C, Dutrieux J, Corneau A, Cosma A, Cheynier R, Dereuddre-Bosquet N, Le Grand R, Vaslin B. 2014. Plasmacytoid dendritic cell dynamics tune interferon-alfa production in SIV-infected cynomolgus macaques. PLoS Pathog 10:e1003915. http://dx.doi.org/10.1371/journal.ppat.1003915.
25. Ferbas JJ, Toso JF, Logar AJ, Navratil JS, Rinaldo CR, Jr. 1994. CD4+ blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection. J Immunol 152:4649-4662.
26. Tilton JC, Manion MM, Luskin MR, Johnson AJ, Patamawenu AA, Hallahan CW, Cogliano-Shutta NA, Mican JM, Davey RT, Jr, Kottilil S, Lifson JD, Metcalf JA, Lempicki RA, Connors M. 2008. Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. J Virol 82: 3997-4006. http://dx.doi.org/10.1128/JVI.01545-07.
27. Lehmann C, Harper JM, Taubert D, Hartmann P, Fatkenheuer G, Jung N, van Lunzen J, Stellbrink HJ, Gallo RC, Romerio F. 2008. Increased interferon alpha expression in circulating plasmacytoid dendritic cells of HIV-1-infected patients. J Acquir Immune Defic Syndr 48:522-530. http://dx.doi.org/10.1097/QAI.0b013e31817f97cf.
28. Lehmann C, Lafferty M, Garzino-Demo A, Jung N, Hartmann P, Fatkenheuer G, Wolf JS, van Lunzen J, Romerio F. 2010. Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients. PLoS One 5:e11110. http://dx.doi.org/10.1371/journal.pone.0011110.
29. Beignon AS, McKenna K, Skoberne M, Manches O, DaSilva I, Kavanagh DG, Larsson M, Gorelick RJ, Lifson JD, Bhardwaj N. 2005. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 115:3265-3275. http://dx.doi.org/10.1172/JCI26032.
30. Lepelley A, Louis S, Sourisseau M, Law HK, Pothlichet J, Schilte C, Chaperot L, Plumas J, Randall RE, Si-Tahar M, Mammano F, Albert ML, Schwartz O. 2011. Innate sensing of HIV-infected cells. PLoS Pathog 7:e1001284. http://dx.doi.org/10.1371/journal.ppat.1001284.
31. Piconi S, Parisotto S, Rizzardini G, Passerini S, Terzi R, Argenteri B, Meraviglia P, Capetti A, Biasin M, Trabattoni D, Clerici M. 2011. Hydroxychloroquine drastically reduces immune activation in HIVinfected, antiretroviral therapy-treated immunologic nonresponders. Blood 118:3263-3272. http://dx.doi.org/10.1182/blood-2011-01-329060.
32. Harris LD, Tabb B, Sodora DL, Paiardini M, Klatt NR, Douek DC, Silvestri G, Muller-Trutwin M, Vasile-Pandrea I, Apetrei C, Hirsch V, Lifson J, Brenchley JM, Estes JD. 2010. Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques. J Virol 84:7886-7891. http://dx.doi.org/10.1128/JVI.02612-09.
33. Brown KN, Wijewardana V, Liu X, Barratt-Boyes SM. 2009. Rapid influx and death of plasmacytoid dendritic cells in lymph nodes mediate depletion in acute simian immunodeficiency virus infection. PLoS Pathog 5:e1000413. http://dx.doi.org/10.1371/journal.ppat.1000413.
34. Martin-Martin L, Almeida J, Hernandez-Campo PM, Sanchez ML, Lecrevisse Q, Orfao A. 2009. Immunophenotypical, morphologic, and functional characterization of maturation-associated plasmacytoid dendritic cell subsets in normal adult human bone marrow. Transfusion 49: 1692-1708. http://dx.doi.org/10.1111/j.1537-2995.2009.02170.x.
35. Kamga I, Kahi S, Develioglu L, Lichtner M, Maranon C, Deveau C, Meyer L, Goujard C, Lebon P, Sinet M, Hosmalin A. 2005. Type I interferon production is profoundly and transiently impaired in primary HIV-1 infection. J Infect Dis 192:303-310. http://dx.doi.org/10.1086/430931.
36. Malleret B, Maneglier B, Karlsson I, Lebon P, Nascimbeni M, Perie L, Brochard P, Delache B, Calvo J, Andrieu T, Spreux-Varoquaux O, Hosmalin A, Le Grand R, Vaslin B. 2008. Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression. Blood 112:4598-4608. http://dx.doi.org/10.1182/blood-2008-06-162651.
37. Sabado RL, O'Brien M, Subedi A, Qin L, Hu N, Taylor E, Dibben O, Stacey A, Fellay J, Shianna KV, Siegal F, Shodell M, Shah K, Larsson M, Lifson J, Nadas A, Marmor M, Hutt R, Margolis D, Garmon D, Markowitz M, Valentine F, Borrow P, Bhardwaj N. 2010. Evidence of dysregulation of dendritic cells in primary HIV infection. Blood 116: 3839-3852. http://dx.doi.org/10.1182/blood-2010-03-273763.
38. Lo CC, Schwartz JA, Johnson DJ, Yu M, Aidarus N, Mujib S, Benko E, Hyrcza M, Kovacs C, Ostrowski MA. 2012. HIV delays IFN-alpha production from human plasmacytoid dendritic cells and is associated with SYK phosphorylation. PLoS One 7:e37052. http://dx.doi.org/10.1371/journal.pone.0037052.
39. O'Brien M, Manches O, Sabado RL, Baranda SJ, Wang Y, Marie I, Rolnitzky L, Markowitz M, Margolis DM, Levy D, Bhardwaj N. 2011. Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-alpha-producing and partially matured phenotype. J Clin Invest 121:1088-1101. http://dx.doi.org/10.1172/JCI44960.
40. Diop OM, Gueye A, Dias-Tavares M, Kornfeld C, Faye A, Ave P, Huerre M, Corbet S, Barre-Sinoussi F, Muller-Trutwin MC. 2000. High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys. J Virol 74:7538-7547. http://dx.doi.org/10.1128/JVI.74.16.7538-7547.2000.
41. Chung E, Amrute SB, Abel K, Gupta G, Wang Y, Miller CJ, Fitzgerald-Bocarsly P. 2005. Characterization of virus-responsive plasmacytoid dendritic cells in the rhesus macaque. Clin Diagn Lab Immunol 12:426-435. http://dx.doi.org/10.1128/CDLI.12.3.426-435.2005.
42. Ferbas J, Navratil J, Logar A, Rinaldo C. 1995. Selective decrease in human immunodeficiency virus type 1 (HIV-1)-induced alpha interferon production by peripheral blood mononuclear cells during HIV-1 infection. Clin Diagn Lab Immunol 2:138-142.
43. Ankel H, Westra DF, Welling-Wester S, Lebon P. 1998. Induction of interferon-alpha by glycoproteinDof herpes simplex virus: a possible role of chemokine receptors. Virology 251:317-326. http://dx.doi.org/10.1006/viro.1998.9432.
44. Ritz C, Streibig JC. 2005. Bioassay analysis using R. J Stat Softw 12:1-22.
45. Pacanowski J, Kahi S, Baillet M, Lebon P, Deveau C, Goujard C, Meyer L, Oksenhendler E, Sinet M, Hosmalin A. 2001. Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood 98:3016-3021. http://dx.doi.org/10.1182/blood.V98.10.3016.
46. Martinelli E, Cicala C, Van Ryk D, Goode DJ, Macleod K, Arthos J, Fauci AS. 2007. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-α secretion in plasmacytoid dendritic cells. Proc Natl Acad Sci USA 104:3396-3401. http://dx.doi.org/10.1073/pnas.0611353104.
47. Dzionek A, Sohma Y, Nagafune J, Cella M, Colonna M, Facchetti F, Gunther G, Johnston I, Lanzavecchia A, Nagasaka T, Okada T, Vermi W, Winkels G, Yamamoto T, Zysk M, Yamaguchi Y, Schmitz J. 2001. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med 194:1823-1834. http://dx.doi.org/10.1084/jem.194.12.1823.
48. Pritschet K, Donhauser N, Schuster P, Ries M, Haupt S, Kittan NA, Korn K, Pohlmann S, Holland G, Bannert N, Bogner E, Schmidt B. 2012. CD4-and dynamin-dependent endocytosis of HIV-1 into plasmacytoid dendritic cells. Virology 423:152-164. http://dx.doi.org/10.1016/j.virol.2011.11.026.
49. Ries M, Pritschet K, Schmidt B. 2012. Blocking type I interferon production: a new therapeutic option to reduce the HIV-1-induced immune activation. Clin Dev Immunol 2012:534929. http://dx.doi.org/10.1155/2012/534929.
50. Swiecki M, Wang Y, Gilfillan S, Colonna M. 2013. Plasmacytoid dendritic cells contribute to systemic but not local antiviral responses to HSV infections. PLoS Pathog 9:e1003728. http://dx.doi.org/10.1371/journal.ppat.1003728.
51. Nascimbeni M, Perie L, Chorro L, Diocou S, Kreitmann L, Louis S, Garderet L, Fabiani B, Berger A, Schmitz J, Marie JP, Molina TJ, Pacanowski J, Viard JP, Oksenhendler E, Beq S, Abehsira-Amar O, Cheynier R, Hosmalin A. 2009. Plasmacytoid dendritic cells accumulate in spleens from chronically HIV-infected patients but barely participate in interferon-alpha expression. Blood 113:6112-6119. http://dx.doi.org/10.1182/blood-2008-07-170803.
52. Gianella S, Strain MC, Rought SE, Vargas MV, Little SJ, Richman DD, Spina CA, Smith DM. 2012. Associations between virologic and immunologic dynamics in blood and in the male genital tract. J Virol 86:1307-1315. http://dx.doi.org/10.1128/JVI.06077-11.
53. Handley SA, Thackray LB, Zhao G, Presti R, Miller AD, Droit L, Abbink P, Maxfield LF, Kambal A, Duan E, Stanley K, Kramer J, Macri SC, Permar SR, Schmitz JE, Mansfield K, Brenchley JM, Veazey RS, Stappenbeck TS, Wang D, Barouch DH, Virgin HW. 2012. Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome. Cell 151:253-266. http://dx.doi.org/10.1016/j.cell.2012.09.024.
54. Klatt NR, Harris LD, Vinton CL, Sung H, Briant JA, Tabb B, Morcock D, McGinty JW, Lifson JD, Lafont BA, Martin MA, Levine AD, Estes JD, Brenchley JM. 2010. Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection. Mucosal Immunol 3:387-398. http://dx.doi.org/10.1038/mi.2010.14.